The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase

Journal of Immunology

Volumn 164, Issue 4, 2000, Pages 1934-1939

  Wang, Xiaodong ^a   Gjörloff Wingren, Anette ^a,b   Saxena, Manju ^a   Pathan, Nuzhat ^a   Reed, John C ^a   Mustelin, Tomas ^a  

^a BURNHAM INSTITUTE   (United States)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE;

EID: 0343621512     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.4.1934     Document Type: Article

References (27)

1. Li, J., C. Yen, D. Liaw, K. Podsypanina, S. Bose, S. I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie, et al. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate. Science 275:1943.
2. Li, D. M., and H. Sun. 1997. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res. 57:2124.
3. Steck, P. A., M. A. Pershouse, S. A. Jasser, W. K. A. Yung, H. Lin, A. H. Ligon, L. A. Langford, M. L. Baumgard, T. Hattier, T. Davis, et al. 1997. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nut. Genet. 15:356.
4. Speaks, S. L., W. G. Sanger, A. S. Masih, D. S. Harrington, M. Hess, and J. O. Armitage. 1992. Recurrent abnormalities of chromosome bands 10q23-25 in non-Hodgkin's lymphoma. Genes Chromosomes Cancer 5:239.
5. Takeuchi, S., C. R. Bartram, M. Wada, A. Reiter, Y. Hatta, T. Seriu, E. Lee, C. W. Miller, I. Miyoshi, and H. P. Koeffler. 1995. Allelotype analysis of childhood acute lymphoblastic leukemia. Cancer Res. 55:5377.
6. Teng, D. H., R. Hu, H. Lin, T. Davis, D. Iliev, C. Frye, B. Swedlund, K. L. Hansen, V. L. Vinson, K. L. Gumpper, et al. 1997. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res. 57:5221.
7. Gronbaek, K., J. Zeuthen, P. Guldberg, E. Ralfkiaer, and K. Hou-Jensen. 1998. Alterations of the MMAC1/PTEN gene in lymphoid malignancies. Blood 91: 4388.
8. Eng, C., V. Murday, S. Seal, S. Mohammed, S. V. Hodgson, M. A. Chaudary, I. S. Fentiman, B. A. J. Ponder, and R. A. Eeles. 1994. Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? J. Med. Genet. 31:458.
9. Marsh, D. J., P. L. M. Dahia, Z. Zheng, D. Liaw, R. Parsons, R. J. Gorlin, and C. Eng. 1997. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet. 16:333.
10. Stambolic, V., A. Suzuki, J. L. de la Pompa, G. M. Brothers, C. Mirtsos, T. Sasaki, J. Rulans, J. M. Penninger, D. P. Siderovski, and T. K. Mak. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29.
11. Myers, M. P., J. Stolarov, C. Eng, J. Li, S. I. Wang, M. H. Wigler, R. Parsons, and N. K. Tonks. 1997. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA 94:9052.
12. Maehama, T., and J. E. Dixon. 1998. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylionsitol 3,4,5-trisphosphate. J. Biol. Chem. 273:13375.
13. Myers, M. P., I. Pass, I. H. Batty, J. Van der Kaay, J. P. Stolarov, B. A. Hemmings, M. H. Wigler, C. P. Downes, and N. K. Tonks. 1998. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Prof. Natl. Acad. Sci. USA 95:13513.
14. Auger, K. R., and L. C. Cantley. 1991. Novel polyphosphoinositides in cell growth and activation. Cancer Cells 3:263.
15. Liaw, D., D. J. Marsh, J. Li, P. L. M. Dahia, S. I. Wang, Z. Zheng, S. Bose, K. M. Call, H. C. Tsou, M. Peacocket, et al. 1997. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16:64.
16. Rhei, E., L. Kang, F. Bogomolniy, M. G. Federici, P. I. Borgen, and J. Boyd. 1997. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res. 57:3657.
17. Tashiro, H., M. S. Blazes, R. Wu, K. R. Cho, S. Bose, S. I. Wang, J. Li, R. Parsons, and H. Ellenson. 1997. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 57:3935.
18. Furnari, F. B., H. Lin, H. S. Huang, and W. K. Cavenee. 1997. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc. Natl. Acad. Sci. USA 94:12479.
19. Smith, A., and A. Ashworth. 1998. Cancer predisposition: where's the phosphate? Curr. Biol. 8:241.
20. von Willebrand, M., T. Jascur, N. Bonnefoy Berard, H. Yano, A. Altman, Y. Matsuda, and T. Mustelin. 1996. Inhibition of phosphatidylinositol 3-kinase blocks TCR/CD3-induced activation of the mitogen-activated kinase Erk2. Eur. J. Biochem. 235:828.
21. Couture, C., Z. Songyang, T. Jascur, S. Williams, P. Tailor, L. C. Cantley, and T. Mustelin. 1996. Regulation of the Lck SH2 domain by tyrosine phosphorylation. J. Biol. Chem. 271:24880.
22. 1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA 96:2110.
23. Couture, C., M. Deckert, S. Williams, F. Otero Russo, A. Altman, and T. Mustelin. 1996. Identification of the site in the Syk protein tyrosine kinase that binds the SH2 domain of Lck. J. Biol. Chem. 271:24294.
24. Williams, S., C. Couture, J. Gilman, T. Jascur, M. Deckert, A. Altman, and T. Mustelin. 1997. Reconstitution of TCR-induced Erk2 kinase activation in Lck-negative JCaM1 cells by Syk, but not Zap. Eur. J. Biochem. 245:84.
25. Burgering, B. M., and P. J. Coffer. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599.
26. Franke, T. F., S. I. Yang, T. O. Chan, K. Datta, A. Kazlauskas, D. K. Morrison, D. R. Kaplan, and, P. N. Tsichlis. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727.
27. Datta, S. R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M. E. Greenberg. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231.